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Abstract 
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Galectins are a family of low molecular weight galactoside specific endogenous lectins with 
functions in cell growth, cell activation, cell–cell, cell–matrix adhesion including binding to 
carcinoembryonic antigen, laminin and metalloprotenase. Gal-3 by interacting with T- antigen 
has been found to enhance metastatic potential of human tumors in a number of 
experimental studies. We correlated the endogenous expression patterns of Gal-1, Gal-3 
along with their respective binding sites and T- antigen expression of breast cancer tissues 
of lymph node positive cases with that of lymph node negative cases. A lower cytoplasmic 
expression of Gal-3 and a higher expression of T- antigen were found to differentiate lymph 
node positive cases from node negative cases, suggesting that Gal-3 and T- antigen 
expression analysis can have a role to predict lymph node metastasis in breast cancer 
patients. Further detailed analysis to explore the significance of these markers in breast 
cancer is warranted.  
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Introduction 
The clinical course of breast cancer varies considerably 
from patient to patient; some women have recurrent cancer 
and die within a year of mastectomy, others are cured by 
mastectomy, and still others survive for ten or fifteen years 
after mastectomy with proven metastatic disease. Although it is 
not possible to predict with certainty how a particular breast 
cancer will behave in a particular patient, certain parameters 
are useful in predicting the chance of a woman’s being cured 
or dying of the disease. Axillary lymph node status for the 
presence of metastasis is one of the main parameters among 
them. It has been shown through numerous studies that 
routine histological examination of dissected nodes may be 
inadequate depending on the thoroughness of examination 
[1,2]. Sapir and Amreman have reported that re-examination of 
multiple sections of 30 patients, whose lymph nodes have 
been reported as negative by standard histopathological 
methods revealed 10 patients (33%) to have metastatic 
disease. Working on lymph node specimens from 199 patients, 
it was found that 22% those free of disease on routine 
histopathological examination had occult metastasis on serial 
sectioning. The presence of such metastasis on serial 
sectioning has been shown to confer a significant adverse 
effect on recurrence and survival. The major disadvantages, 
however, are the cost and labor implications in processing 
axillary lymph node through serial sectioning to search for 
occult disease [3]. The consequences of missing axillary micro 
metastasis can directly influence treatment strategies. So, the 
axillary lymph node should be dissected as a unanimous policy 
in clinically axillary node positive patients. But, the need for 
immediate axillary dissection in clinically axillary node negative 
patients has been questioned [4]. The main reason for axillary 
dissection in clinically axillary node negative patients is for the 
staging of breast cancer. But, the chance that axillary node are 
involved is only 20-25% in those patients [5]. If other biological 
markers can accurately assess axillary and internal mammary 
metastasis, unwanted dissection of axillary and internal 
mammary lymph nodes can safely be avoided and at the same 
time the consequence of missing of the occult micro 
metastasis can be eliminated.  
The endogenous lectins, galectin-1 (Gal-1) and galectin-3 
(Gal-3) are a family of low molecular weight galactoside 
specific lectins with functions in cell growth, cell activation, 
cell–cell, cell–matrix adhesion including binding to 
carcinoembryonic antigen, laminin and metalloprotenase [6]. 
galectin-3 and galectin-1 have been found to enhance 
metastatic potential of human tumors by interacting with T- 
antigen in a number of experimental studies. A recent study on 
the implication of Gal-3 function during metastasis of breast 
carcinoma cells suggest that Gal-3 is a critical determinant for 
anchorage–independent and free–radical resistant cell survival 
during metastasis [7]. Down regulation of Gal-3 was reported 
to suppress the tumorigenicity human breast carcinoma cells 
[8]. The endogenous galectins and their respective binding 
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sites can be demonstrated by specific antibodies directed 
against them and by using biotinated galectins respectively. 
Apart from the molecule for which a role in cell-cell and 
cell-extra cellular matrix interaction has been mentioned, other 
molecules may also be involved in the development, 
progression and metastasis of tumor. The Thomson 
Friedenreich (T) antigen, which is a protein linked galectose -
1-3-N-acetylgalactosamine strain, is one among them. A 
significant role for T- antigen has been reported in the 
progression of breast cancer [9,10].  In a recent study on the 
role of T- antigen in adhesion of human breast and prostate 
cancer cells to endothelium has demonstrated that T- antigen 
plays a leading role in the docking of breast and prostate 
cancer cells onto endothelium by specifically interacting with 
endothelium expressed Gal-3. The T- antigen bearing 
glycoproteins are also capable of mobilizing Gal-3 to the 
surface of endothelial- cells, thus priming them for harboring 
metastatic cancer cells. The expression of T- antigen can be 
demonstrated by monoclonal anti T- antigen antibody.  
 The aim of the present study was to characterize the 
level of expression of Gal-1, Gal-3, their respective binding 
sites and T- antigen expression in primary breast cancer 
tissues of axillary lymph node negative and axillary lymph node 
positive breast cancer patients to know whether any of this 
markers can be used to predict occult micro metastasis in 
tissues of primary breast carcinoma. 
Materials and Methods  
 Paraffin sections from archival blocks of 54 patients of 
primary breast carcinoma tissues removed during the year 
2000-2001 by modified radical mastectomy in the division of 
surgical oncology, Regional Cancer Center, Trivandrum were 
used for the study. Representative blocks were selected by 
reviewing the H&E sections used for the initial diagnosis. 
Clinical details of the lymph node status were obtained from 
the case records of the patients and from histopathology 
records. All the procedures followed in the study were in 
accordance with the ethical standards of the center. 
Antigalectin-1 and antigalectin-3antibodies and 
biotinylated galectin-1 and galectin-3 were kindly supplied by 
Gabius. H.J. Anti T antibody directed against Thomson 
Friedenriech antigen was purchased from DAKO (monoclonal 
mouse anti human Thomson Friedenriech antigen clone HB-
T1). The standard avidine biotin method was followed with 
DAB as the chromogen. The sections were incubated with 
primary antibodies/biotinylated lectins at 4OC for overnight.  
Anti- galectin antibodies were used in concentration of 0.04g / 
mL and the T- antigen antibody in a concentration of 1/50 
dilution. The biotynilated lectins were used in a final 
concentration of 0.05 g /mL. Negative controls were included 
for each batch. The sections were then counterstained with 
haematoxylene for two minutes, dehydrated in ascending 
grades of alcohol and mounted in DPX. 
The slides were assessed in a semi quantitative method. 
The whole area of the sections were examined under10 x 
objective. The staining intensity and the percentage of cells 
with different grades of staining were assessed in each of the 
sections. Areas of sections with the highest percentage of 
positive stained cells were chosen to score. The grades of 
staining were assessed as (0), for negative, (+) for mild, (++) 
for moderate and (+++) for intense. Univariate statistics was 
performed to calculate the mean score for each of the 
markers in lymph node positive and negative samples.  
Significance (two tailed p) was assessed using students T test. 
Results 
 The mean score values for the expression patterns of 
galectin-3, galectin-1, their respective binding sites and T-
antigen in infiltrating duct cell-carcinoma of axillary lymph node 
positive and negative breast cancer tissues are shown in the 
table (I). Samples with lymph node metastasis showed 
predominance of mild grade of staining with a mean value of 
51.03 for gal-3. Where as, in samples without axillary node 
metastasis, cells with moderate expression were higher with a 
mean value of 58.20.Intense expression of Gal-3 was confined 
to samples without metastasis only with a mean value of 8. 
Similarly a higher number of samples with metastasis showed 
predominance of mild grade of gal-1 expression. Moderate 
grade of expression was higher in samples without node 
metastasis; the difference was statistically significant 
(p=0.001). The difference between node positive and node 
negative samples with regard to grade of staining for galectin-1 
expression was lesser than galectin-3. Intense grade of 
expression of Gal-3 were confined to node negative samples 
alone with a mean value of 8. Moderate grade of Gal-1 
expression was higher for samples without metastasis. But the 
difference was not as much significant as that of Gal-3. No 
significant differences between node negative and positive 
samples were observed for either of the galectin binding sites. 
The mean values for Gal-3 biding site were 43.28(+), 
16.21(++) and for Gal-1biding site 42.91(+), 8.79(++) for 
samples with lymph node metastasis and 39, 15 and 37and 11 
for samples without lymph node metastasis. The expression 
patterns for both of the galectins and for the respective binding 
sites were uniform, regular and mainly cytoplasmic (Fig. 1-
A,B,C,D) 
Mild nuclear expression was found in two of the cases for 
galectin-3. Expression of galectin-3 as well as galectin-1 were 
seen in the stroma also.  
The mean value for mild grade of T-antigen expression 
was 2.93 for samples with lymph node metastasis and 8 for 
samples with out metastasis. Moderate grade of expression 
was higher in node positive cases with a mean value of 37.07. 
Significant difference was observed in the moderate grade of 
expression of T- antigen between samples with lymph node 
metastasis and samples without metastasis (P=0.000). Intense 
grade of staining was confined to node positive cases only and 
the mean value was 5.52. The expression was uniform regular, 
and mainly membrane. However, cytoplasmic expression was 
also seen.in all of the samples.  Fig.(1-E,F).
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Fig I: 
A. Intense expression of Galectin-1 in the cytoplasm of the malignant cells of infiltrating duct cell carcinoma.100x10 
B. Intense expression of Galectin-3 in the cytoplasm of the malignant cells of infiltrating duct cell carcinoma.100x10 
C. Intense expression of Galectin-1 binding site in the cytoplasm of the malignant cells of infiltrating duct cell carcinoma.100x10 
D. Intense expression of Galectin-3 in the cytoplasm of the malignant cells of infiltrating duct cell carcinoma.100x10 
E. Intense expression of T-antigen in malignant cells of infiltrating duct cell carcinoma.40x10 
F. Intense expression of T-antigen in malignant cells of infiltrating duct cell carcinoma 100x10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 2: Bar graph showing the patterns of expression of Gal-3, Gal-1 and T-antigen. 
 
Table I: Univariate statistics of the different grades of endogenous expression of Gal-3,Gal-1 and their respective binding sites and T antigen 
 
Intensity of 
expressions in 
grades 
 Univariate statistics of different grades of expressions 
Mean Standard deviation Standard error mean T value Significance 
Two tailed p M 
(n=29) 
NM 
(n=25) 
M 
(n=29) 
 
NM 
(n=25) 
M 
(n=29) 
NM 
(n=25) 
Galectin-3  
51.03 
 
 
14 
 
36.92 
 
31.52 
 
6.86 
 
6.30 
 
3.929 
 
0.000 + 
 
++ 
 
22.59 
 
 
58.20 
 
37.07 
 
39.58 
 
6.88 
 
7.92 
 
3.412 
 
0.001 
 
+++ 
 
 
0 
 
 
8 
 
0 
 
10.21 
 
0 
 
2.04 
 
2.939 
 
0.007 
Galectin-1         
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+ 50 30.20 35.98 41.21 6.68 8.25 0.457 0.650 
 
++ 
 
10.9 
 
24.40 
 
24.35 
 
33.21 
 
4.52 
 
6.64 
 
1.719 
 
0.092 
 
+++ 
 
0 
 
0 
      
Binding site for Gal-
3 
 
 
43.28 
 
 
39 
 
 
29.35 
 
 
29.86 
 
 
5.45 
 
 
5.95 
 
 
0.777 
 
 
0.441 + 
 
++ 
 
16.21 
 
15 
 
20.29 
 
25 
 
3.77 
 
5 
 
1.404 
 
0.167 
 
+++ 
 
0 
 
0 
      
Binding site for Gal-
1 
 
 
42.91 
 
 
37 
 
 
28.87 
 
 
22.96 
 
 
5.36 
 
 
4.59 
 
 
0.754 
 
 
0.454 + 
 
++ 
 
8.79 
 
11 
 
23.93 
 
20.51 
 
4.44 
 
4.10 
 
-.361 
 
0.720 
 
+++ 
 
0 
 
0 
      
T- antigen   
2.93 
 
8 
 
7.85 
 
8.42 
 
1.46 
 
1.68 
 
2.288 
 
0.026 + 
 
++ 
 
37.07 
 
3.20 
 
26.03 
 
10.19 
 
4.83 
 
2.04 
 
6.456 
 
0.000 
 
+++ 
 
5.52 
 
0 
 
12.42 
 
0 
 
2.31 
 
0 
 
2.393 
 
0.024 
 
Discussion 
 The recent findings demonstrate that hematogeneous 
cancer metastasis originate from intra vascular growth of 
endothelium attached rather than extra vasated cancer cells 
emphasizing the key role of tumor endothelial cell interaction in 
the phenomenon of metastasis [11]. A broad array of adhesion 
molecules has been implicated in the adhesion of tumor cells 
to vascular endothelium. The different adhesion molecules are 
thought to participate at distinct stages of this multi step 
binding process. Galectin–3 has been proposed to participate 
in docking of cancer cells onto the capillary endothelium [12]. 
Studies on cellular distribution of Gal-3 during cancer cell 
adhesion to endothelium has been reported by Vladislave et al. 
[13]. They used laser scanning confocal microscopy to study 
the localization of Gal-3 in both cancer cells and endothelial 
cells upon their interaction and have found Gal-3 distributing 
during breast cancer cell adhesion to endothelial cells. They 
observed extra cellular expression of Gal-3 in cultured tumor 
cells than endothelial cells and suggested that Gal-3 of cancer 
cells does not actually participate in their adhesion to 
endothelium, in contrast, they observed the mobilization and 
clustering of Gal-3 endothelial cells towards the cancer 
endothelial cell contacts. They have also analyzed the 
interaction of T- antigen with Gal-3 as the terminal sugar of T- 
antigen is beta- galactoside and considering the fact that 
human Gal-3 exhibit a 200 fold higher specific activity towards 
Gal beta 1-3 Gal NAc disaccharide than Gal-1. It was also 
observed that both T- antigen masking and T- antigen 
mimicking compounds specifically inhibited the interaction of 
Gal-3 with T- antigen on ELISA experiments confirming the 
interaction. There are several reports correlating galectin 
expression and tumor metastasis. Galectin –3 has been 
reported as a useful tumor marker for gastric cancers with 
respects to tumor progression and potentiality of lymph node 
metastasis [14] Cindolo et al. [15] have reported a higher 
expression pattern of Gal-1 and Gal-3 correlating with the 
grade of tumor in transitional cell carcinoma. While a 
comparative analysis of galectin in primary and metastatic 
pancreatic cancer revealed no significant relation between 
galectin expression and tumor grade [16].  Galectin-3 has been 
reported to enhance the metastatic potential of BT 549 cells 
through resistance to the product of iNOS, possibly through its 
bcl-2-like ant apoptotic function [17]. Andre [18] has analyzed 
the expression of Gal-1 and Gal-3 and their binding sites in 
node negative and node positive breast cancer tissues and has 
reported that correlation of either increased Gal-1 binding and 
reduced gal-3 binding or reduced binding of both galectins with 
the occurrence of lymph node lesions. Idikio [19] also has 
reported a reduction of Gal-3 expression, which correlates with 
the higher grade of breast cancer that possibly reduced matrix 
binding and increased cancer cell motility.  
The present study confirms the immuno-histochemical 
demonstration of galectins and their respective binding sites in 
formalin fixed tissues. Even though galectin expression were 
found in breast cancer tissues irrespective of the lymph node 
status, significantly higher expression of Gal-3 was observed in 
the breast cancer tissue samples of lymph node negative 
patients than node positive cases. Despite a higher percentage 
of cells with mild grade of expression was seen in samples with 
lymph node metastasis, moderate grade of expression was 
significantly higher in samples with out lymph node metastasis 
(p=0.001). Cells with intense grade of expression, even though 
lesser in number, were observed in samples without lymph 
node metastasis only. A slight higher expression for Gal-1 was 
also observed in node negative samples but it was not 
significant as observed for Gal-3. Thus, the present study 
confirms the observations of the previous reports of Andres 
and Idikio [18,19]. But, for the biding sites of Gal-1 as well as 
Gal-3, no significant difference were observed between lymph 
node positive and negative samples.  
Springer and colleagues were the first to propose T- 
antigen as a tumor associated antigen in man. They have 
demonstrated T- antigen in breast tissues, gastrointestinal tract 
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and respiratory tract tissues [20]. T- antigen has been reported 
to play a major role in determining the invasive and metastatic 
properties of tumor cells [21]. T- antigen expression has been 
reported to correlate with tumor recurrence in transitional cell 
carcinoma of the bladder [22]. In another study the T- antigen 
expression has been correlated with nuclear volume in relation 
to recurrence and prognosis of cancer of the bladder [23]. They 
have found T- antigen expression in 54% of the patients who 
had invasive disease. Similarly a higher nuclear volume also 
suggested invasive disease, indicating that the combined use 
of T- antigen expression and mean nuclear volume is of 
potential clinical interest for determining patients who are at 
high risk of disease progression. Sata et al.[24] have reported 
the usefulness of gold-labeled amerantin for the detection of T- 
antigen and its cryptic form in normal, dysplastic and 
neoplastic colonic epithelium. They have found that T- antigen 
was expressed in normal and dysplastic and neoplastic colonic 
epithelium in the cryptic form only. In breast carcinoma, the 
relative proportion of T- antigen and Tn antigen has been 
reported to correlate with the tumor aggressiveness [25]. While 
Imai et al. [26] has analyzed the expression patterns of T- and 
Tn antigen in breast carcinoma and have reported that a 
significant inverse correlation has been found between the 
expression of T/Tn antigen expression and long term overall 
survival.  Howard etal. [27] and Klein et al. [28] have suggested 
that the T antigen can be detected by PNA, the plant lectin 
binding and have a role in the modulation of host immune 
response to breast carcinoma. They also found that in benign 
breast tissues and in well-differentiated areas of neoplastic 
lesions T- antigen is located in the luminal membrane and they 
considered it as outside the body of cell or in an 
immunologically privileged site. T- antigen has been reported 
to be present in upto 91% of breast carcinomas and the high 
frequency of it has been exploited to identify micro metastasis 
on axillary lymph nodes by PNA reactivity [29]. As PNA reacts 
with ordinary D-galactopyranose residues, D-galactosamine, 
alpha linked D-glucosamine and even to D-fucose, this plant 
lectin is not specific for T- antigen and anti T- antigen antibody 
is more specific to demonstrate T antigen.  
In the present study, T- antigen expression was observed 
in 48 samples of the total 54 samples studied. Among the T 
antigen positive samples, mild grade of expression were the 
predominant pattern in breast cancer tissues of the node 
negative patients. Whereas, moderate and intense expression 
patterns were observed in lymph node positive cases. None of 
the lymph node negative samples showed intense grade of 
expression. So the present study observed a positive 
correlation between T- antigen expression and axillary 
lymphnode metastasis. Here also the expression was mainly 
membrane as reported by Howard by using PNA.  However, 
cytoplasmic expression was also seen in almost all the cases. 
They have further shown that T- antigen acts both as a major 
cell surface carbohydrate ligand for Gal-3 on breast cancer 
cells and as a factor causing mobilization of Gal-3 to the outer 
membrane on endothelial cells. A similar explanation can be 
offered for the lower level expression of Gal-3 and a higher 
expression of T- antigen in samples of lymph node positive 
cases than the samples of lymph node negative cases. 
Thus, a higher T- antigen expression and a lower Gal-3 
expression pattern appear to differentiate primary breast 
carcinoma with axillary lymph node metastasis form breast 
carcinoma without axillary lymph node metastasis. This 
preliminary report suggests further detailed evaluation of the 
potential of galectins and T- antigen in predicting occult micro 
metastasis in primary breast carcinoma tissues. 
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